Water-Soluble and Low Molecular Weight Chitosan-Based Plasmid DNA Delivery

AbstractPurpose. Chitosan, a natural cationic polysaccharide, is a candidate non-viral vector for gene delivery because of its high positive charges and low cytotoxicity. In this study, low molecular weight chitosan (LMWC, molecular weight of 22 kDa) was characterized and evaluated as a gene carrier. Methods. Plasmid/LMWC complex was analyzed in 1% agarose gel electrophoresis. To confirm that the LMWC protected plasmids from nuclease, DNase I protection assays were performed. pSV-β-galactosidase plasmid/LMWC complex was transfected into 293T cells and transfection efficiency was evaluated by β-galactosidase assay. Cytotoxicity of LMWC was determined by MTT assay. Results. Unlike high molecular weight chitosan (HMWC), LMWC is highly water soluble, and can form complex with plasmids in physiological buffer. The plasmid DNA was completely retarded at a weight ratio of 1:2 (plasmid:LMWC) in 1% agarose gel. DNase I protection assay showed that plasmids were protected from DNase I over 60 min. The most efficient transfection was obtained at a weight ratio of 1:3 (plasmid:LMWC). The transfection efficiency of LMWC was significantly higher than naked DNA and higher than poly-L-lysine (PLL). MTT assay showed that LMWC was less cytotoxic than PLL. Conclusions. LMWC is non-toxic and has higher transfection efficiency than PLL. Therefore, LMWC will be useful in the development of safe gene carriers.

[1]  R. Duncan,et al.  Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. , 1999, International journal of pharmaceutics.

[2]  K. E. Gabr,et al.  Effect of interpolymer complex formation of chitosan with pectin or acacia on the release behaviour of chlorpromazine HCl , 1993 .

[3]  V. Cofman.  Biophysical chemistry. Part II , 1929 .

[4]  James M. Wilson,et al.  Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. , 1989, The Journal of biological chemistry.

[5]  J. Behr.  Synthetic Gene‐Transfer Vectors , 1993 .

[6]  C. Cantor,et al.  Biophysical chemistry. Part III, The behavior of biologicalmacromolecules , 1980 .

[7]  K. Zatloukal,et al.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Masada,et al.  Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. , 1990, Chemical & pharmaceutical bulletin.

[9]  M. Cotten,et al.  Transferrin-polycation conjugates as carriers for DNA uptake into cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T. Bettinger,et al.  Chitosan-Based Vector/DNA Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability , 1998, Pharmaceutical Research.

[11]  C. Wu,et al.  Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers. , 1994, Nucleic acids research.

[12]  R. Mumper,et al.  Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[14]  J. Kennedy,et al.  Progress in biomedical polymers. Edited by C. G. Gebelein and R. L. Dunn, Plenum Press, New York, 1990. pp, 406, price $8950 ($107.40 outside US and Canada). ISBN 0‐306‐43523‐3 , 1991 .

[15]  M. Monsigny,et al.  Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. , 1996, Human gene therapy.

[16]  A. Kabanov,et al.  DNA complexes with polycations for the delivery of genetic material into cells. , 1995, Bioconjugate chemistry.

[17]  F. Orson,et al.  Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. , 1999, Human gene therapy.

[18]  T. Chandy,et al.  Chitosan--as a biomaterial. , 1990, Biomaterials, artificial cells, and artificial organs.

[19]  C. Caskey,et al.  Non-viral approaches to gene therapy. , 1995, British medical bulletin.

[20]  R. Mumper,et al.  Novel polymeric condensing carriers for gene delivery , 1995 .

[21]  F. Liu,et al.  Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Y. George.  Receptor-mediated in Vitro Gene Transformation by a Soluble DNA Carrier System , 2022 .

[23]  M. Cotten,et al.  Non-viral approaches to gene therapy. , 1993, Current opinion in biotechnology.

[24]  M. Monsigny,et al.  Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. , 1993, Nucleic acids research.

[25]  C. Wu,et al.  Receptor-mediated gene delivery and expression in vivo. , 1988, The Journal of biological chemistry.

[26]  A. Miller,et al.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.

[27]  V. Torchilin,et al.  Use of N-terminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells. , 1992, Bioconjugate chemistry.

[28]  J. Armendáriz-Borunda,et al.  Nonenzymatic glycosylation of poly‐l‐lysine: A new tool for targeted gene delivery , 1994, Hepatology.

[29]  I. Kwon,et al.  Preparation of chitosan self-aggregates as a gene delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[30]  H. Saitǒ,et al.  Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans , 1991 .

[31]  J. Wilson,et al.  Adenoviruses as gene-delivery vehicles. , 1996, The New England journal of medicine.

[32]  H. Temin.  Safety considerations in somatic gene therapy of human disease with retrovirus vectors. , 1990, Human gene therapy.